ACI
TECH icon

AMP Capital Investors’s Bio-Techne TECH Stock Holding History

AMP Capital Investors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,328
Closed -$2.71M – 893
2021
Q3 		$2.71M Sell
22,328
-1,964
-8% -$239K 0.01% 679
2021
Q2 		$2.73M Buy
+24,292
New +$2.56M 0.01% 715
2018
Q3 		– Sell
-9,600
Closed -$355K – 1197
2018
Q2 		$355K Buy
+9,600
New +$367K ﹤0.01% 1046
2014
Q2 		– Sell
-20,428
Closed -$432K – 1256
2014
Q1 		$432K Sell
20,428
-22,772
-53% -$512K ﹤0.01% 987
2013
Q4 		$1.02M Sell
43,200
-48,000
-53% -$1.04M 0.01% 863
2013
Q3 		$1.83M Sell
91,200
-12,400
-12% -$235K 0.01% 717
2013
Q2 		$1.79M Buy
+103,600
New +$1.72M 0.01% 733

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AMP Capital Investors's TECH Position: Q4 2021 in Review

AMP Capital Investors sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 22,328 shares — an estimated $2.71M sold.

AMP Capital Investors first reported a position in TECH in Q2 2013 and held it in 7 quarters. The position peaked at $2.73M in Q2 2021. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

  • AMP Capital Investors reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 22,328 Bio-Techne shares in Q4 2021, an estimated $2.71M.
  • AMP Capital Investors first reported a position in Bio-Techne in Q2 2013 and held it in 7 quarters.
  • AMP Capital Investors's Bio-Techne position peaked at $2.73M in Q2 2021.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.